BDBM50262778 (4-(1H-benzo[d]imidazol-2-yl)piperazin-1-yl)(1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)methanone::CHEMBL477996

SMILES COc1cccc(c1)-n1cc(nc1-c1ccc(C)cc1)C(=O)N1CCN(CC1)c1nc2ccccc2[nH]1

InChI Key InChIKey=JFAUXWSKAIYVEJ-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50262778   

TargetCholecystokinin receptor type A(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262778((4-(1H-benzo[d]imidazol-2-yl)piperazin-1-yl)(1-(3-...)
Affinity DataEC50:  9.10nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed
TargetCholecystokinin receptor type A(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262778((4-(1H-benzo[d]imidazol-2-yl)piperazin-1-yl)(1-(3-...)
Affinity DataIC50: 17nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
1/11/2010
Entry Details Article
PubMed